NeuShen Therapeutics is a biotechnology company developing novel therapies for psychiatric and neurological disorders
NeuShen Therapeutics is a biotechnology company developing novel therapies for psychiatric and neurological disorders. Its pipeline includes small-molecule drug candidates and gene therapies using CNS-tropic AAV capsids and gene-expression cassettes. Clinical programs include an M4 muscarinic acetylcholine receptor positive allosteric modulator for schizophrenia and agitation associated with Alzheimer's disease.